Analysis of mutation frequencies of the BRCA1 5382insC and BRCA2 6174delT genes in the population of Ufa city

Abstract

BACKGROUND: Currently, there is an acute problem of assessing the real genetic danger and the impact of environmental pollution on human health. One of the cities that is affected by the whole complex of anthropogenic mutagenic factors is Ufa (Republic of Bashkortostan).

AIM: The aim of the study was to analyze the frequency of pathogenic mutations in the BRCA1 5382insC and BRCA2 6174delT genes in healthy residents of an industrial city.

MATERIALS AND METHODS: The mutations were determined by real-time PCR using the TaqMan probe technology on the Bio-Rad CFX96 device (Bio-Rad, USA) in accordance with protocol in 379 DNA samples of healthy residents of average age (18.32 ± 0.45 years).

RESULTS: The total mutations frequency in the BRCA1 and BRCA2 genes reached 4.22% (n = 16). The highest frequency of mutant alleles in the BRCA1 and BRCA2 genes of 6.18% (n = 11) was present in residents of the 1 observation area, where petrochemical production enterprises are concentrated. The mutant homozygous genotype of the BRCA2 gene was detected in 3.37% of cases only among residents of the 1 observation area (n = 6, p = 0.0002). The risk of formation of mutations in the BRCA2 gene is 6 times higher in residents of the 1 observation area (χ² = 7.75; df 1; p = 0.006; OR 6.31; 95% CI 1.44–27.67).

CONCLUSIONS: The frequency of the BRCA family genes varies depending on the studied region, the degree of environmental pollution and the studied group.

Keywords

BRCA / DNA mutational analysis / gene frequency / air pollution

References

[1] Ingel FI. Part 2. Environmental Factors and Individual Features in System of Evaluation of Human Genome Instability. Additional Capability of the Test The Technique For Cytogenetic Analysis. Ecological genetics. 2006;4(4):38–54. (In Russ.) DOI: 10.17816/ecogen4438-54

[2] Ингель Ф.И. Перспективы использования микроядерного теста на лимфоцитах крови человека, культивируемых в условиях цитокинетического блока. Часть 2. Факторы среды и индивидуальные особенности в системе нестабильности генома человека. Дополнительные возможности теста. Методика проведения экспериментов и цитогенетического анализа // Экологическая генетика. 2006. Т. 4, № 4. С. 38–54. DOI: 10.17816/ecogen4438-54

[3] Mylavarapu S, Das A, Roy M. Role of BRCA Mutations in the Modulation of Response to Platinum Therapy. Front Oncol. 2018;8:16. DOI: 10.3389/fonc.2018.00016

[4] Mylavarapu S., Das A., Roy M. Role of BRCA Mutations in the Modulation of Response to Platinum Therapy // Front Oncol. 2018. Vol. 8. P. 16. DOI: 10.3389/fonc.2018.00016

[5] Tan SLW, Chadha S, Liu Y, et al. A class of environmental and endogenous toxins induces BRCA2 haploinsufficiency and genome instability. Cell. 2017;169(6):1105–1118.e15. DOI: 10.1016/j.cell.2017.05.010

[6] Tan S.L.W., Chadha S., Liu Y., et al. A class of environmental and endogenous toxins induces BRCA2 haploinsufficiency and genome instability // Cell. 2017. Vol. 169, No. 6. P. 1105–1118.e15. DOI: 10.1016/j.cell.2017.05.010

[7] Maxwell KN, Domchek SM, Nathanson KL, Robson ME. Population frequency of germline BRCA1/2 mutations. J Clin Oncol. 2016;34(34):4183–4185. DOI: 10.1200/jco.2016.67.0554

[8] Maxwell K.N., Domchek S.M., Nathanson K.L., Robson M.E. Population frequency of germline BRCA1/2 mutations // J Clin Oncol. 2016. Vol. 34, No. 34. P. 4183–4185. DOI: 10.1200/jco.2016.67.0554

[9] Rebbeck TR, Friebel TM, Friedman E, et al. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat. 2018;39(5):593–620. DOI: 10.1002/humu.23406

[10] Rebbeck T.R., Friebel T.M., Friedman E., et al. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations // Hum Mutat. 2018. Vol. 39, No. 5. P. 593–620. DOI: 10.1002/humu.23406

[11] Connor F, Bertwistle D, Mee PJ, et al. Tumorigenesis and a DNA repair defect in mice with a truncating BRCA2 mutation. Nat Genet. 1997;17:423–430. DOI: 10.1038/ng1297-423

[12] Connor F., Bertwistle D., Mee P.J., et al. Tumorigenesis and a DNA repair defect in mice with a truncating BRCA2 mutation // Nat Genet. 1997. Vol. 17. P. 423–430. DOI: 10.1038/ng1297-423

[13] Zeinomar N, Oskar S, Kehm RD, et al. Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature. Environ Res. 2020;187:109346. DOI: 10.1016/j.envres.2020.109346

[14] Zeinomar N., Oskar S., Kehm R.D., et al. Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature // Environ Res. 2020. Vol. 187. ID109346. DOI: 10.1016/j.envres.2020.109346

[15] Upravlenie Federal’noi sluzhby po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka po Respublike Bashkortostan. Gosudarstvennyi doklad o sostoyanii prirodnykh resursov i okruzhayushchei sredy Respubliki Bashkortostan v 2020 godu. Ufa: Samrau, 2021. 287 p. (In Russ.)

[16] Управление Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека по Республике Башкортостан. Государственный доклад о состоянии природных ресурсов и окружающей среды Республики Башкортостан в 2020 году. Уфа: Самрау, 2021. 287 с.

[17] Upravlenie Federal’noi sluzhby po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka po Respublike Bashkortostan. Materialy k gosudarstvennomu dokladu “O sostoyanii sanitarno-ehpidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2019 godu” po Respublike Bashkortostan. Ufa: Upravlenie Federal’noi sluzhby po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka po Respublike Bashkortostan, 2020. 262 p. (In Russ.)

[18] Управление Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека по Республике Башкортостан. Материалы к государственному докладу «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2019 году» по Республике Башкортостан. Уфа: Управление Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека по Республике Башкортостан, 2020. 262 с.

[19] Berdina LM, Khusnutdinova EK. Frequency of chromosome aberrations in the population of the Republic of Bashkortostan. Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki. 2006;148(3):189–196. (In Russ.)

[20] Бердина Л.М., Хуснутдинова Э.К. Частота хромосомных аберраций у жителей Республики Башкортостан // Ученые записки Казанского университета. Серия Естественные науки. 2006. Т. 148, № 3. С. 189–196.

[21] Tselousova OS, Ovsyannikova LB. Kompleksnaya gigienicheskaya otsenka ehkologo-geneticheskogo riska zdorov’yu naseleniya promyshlennogo goroda. ХII all-Russian science conference “Zdorov’e cheloveka v XXI veke”; 2020 Oct 28–29; Kazan. P. 242–245. (In Russ.)

[22] Целоусова О.С., Овсянникова Л.Б. Комплексная гигиеническая оценка эколого-генетического риска здоровью населения промышленного города // ХII Всероссийская научно-практическая конференция с международным участием «Здоровье человека в XXI веке»; Октябрь 28–29, 2020; Казань. С. 242–245.

[23] Kochetova OV, Gainullina MK, Victorova TV. Polymorphism of DNA repair genes (XRCC1, XRCC3, XPD, XPC) and risk of uterine myoma among women working in petrochemical complex. Ecological genetics. 2011;9(4):43–51. (In Russ.) DOI: 10.17816/ecogen9443-51

[24] Кочетова О.В., Гайнуллина М.К., Викторова Т.В. Полиморфные варианты генов репарации ДНК (XRCC1, XRCC3, XPD, XPC) и риск развития миомы матки у работниц нефтехимического комплекса // Экологическая генетика. 2011. Т. 9, № 4. С. 43–51. DOI: 10.17816/ecogen9443-51

[25] Bermisheva MA, Zinnatullina GF, Gilyazova IR, et al. Prevalence of BRCA1 c.5161C>T mutation in cancer patients from Bashkortostan. Advances in molecular oncology. 2021;8(4):84–93. (In Russ.) DOI: 10.17650/2313-805X-2021-8-4-84-93

[26] Бермишева М.А., Зиннатуллина Г.Ф., Гилязова И.Р., и др. Распространенность мутации c.5161C>T гена BRCA1 у пациентов с онкологическими заболеваниями из Республики Башкортостан // Успехи молекулярной онкологии. 2021. Т. 8, № 4. С. 84–93. DOI: 10.17650/2313-805X-2021-8-4-84-93

[27] Grijbovsky AM. Analysis of nominal data (independents observations). Ecological genetics. 2008;6:58–68. (In Russ.)

[28] Гржибовский А.М. Анализ номинальных данных (независимые наблюдения) // Экология человека. 2008. Т. 6. С. 58–68.

[29] Fox N, Hunn A, Mathers N. Sampling and sample size calculation. Yorkshire & the Humber: The NIHR RDS for the East Midlands, 2007. 41 p.

[30] Fox N., Hunn A., Mathers N. Sampling and sample size calculation. Yorkshire & the Humber: The NIHR RDS for the East Midlands, 2007. 41 p.

[31] Narkevich AN, Vinogradov KA. Methods for determining the minimum required sample size in medical research. Social aspects of population health. 2019;65(6):10. (In Russ.) DOI: 10.21045/2071-5021-2019-65-6-10

[32] Наркевич А.Н., Виноградов К.А. Методы определения минимально необходимого объема выборки в медицинских исследованиях // Социальные аспекты здоровья населения. 2019. Т. 65, № 6. С. 10. DOI: 10.21045/2071-5021-2019-65-6-10

[33] Collins JM, Isaacs C. Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer. Breast J. 2020;26(8):1520–1527. DOI: 10.1111/tbj.13970

[34] Collins J.M., Isaacs C. Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer // Breast J. 2020. Vol. 26, No. 8. P. 1520–1527. DOI: 10.1111/tbj.13970

[35] Galinskaya TV, Schepetov DM, Lysenkov SN. Prejudices against microsatellite studies and how to resist them. Russian Journal of Genetics. 2019;55(6):617–632. (In Russ.) DOI: 10.1134/S0016675819060043

[36] Галинская Т.В., Щепетов Д.М., Лысенков С.Н. Предубеждения о микросателлитных исследованиях и как им противостоять // Генетика. 2019. Т. 55, № 6. С. 617–632. DOI: 10.1134/S0016675819060043